PSS Strengthens Relationship With Mediplus

PSS Urology, known mainly for the QuickFire Series™ Bipolar Electrodes that provide disruptive technology to the Urological Surgical Device Market, is also the exclusive provider of the S-CathTM System from Mediplus, a unique and complete kit for suprapubic catheterization.

SPOKANE, Wash., /PRNewswire/ -- PSS Urology, known mainly for the QuickFire Series™ Bipolar Electrodes that provide disruptive technology to the Urological Surgical Device Market, is also the exclusive provider of the S-CathTM System from Mediplus, a unique and complete kit for suprapubic catheterization. Mediplus is a worldwide supplier of devices for Urology and other specialties: http://www.s-cath.com/

PSS Urology Logo (PRNewsfoto/PSS Urology, Inc.)

The S-CathTM System is the standard of care in the U.K. and is enjoying rapid adoption in the U.S. Market.

Utilizing the Seldinger Technique, The S-CathTM System offers several advantages to both the clinical staff and the patient:

“This (Mediplus S-Cath System) Is the SAFEST suprapubic catheter (SPC) our customers have ever used.” (Andrew Myatt, Consultant Urologist, Hull Royal Infirmary, UK.

  1. Greater control and accuracy. A high degree of control allows accurate placement.
  2. Reduced risk. Low risk of trauma and tissue damage for the patient. When compared to other Suprapubic Catheter Kits, the S-Cath provides a less traumatic approach, yet provides similar drainage benefits of larger devices.
  3. Greater confidence. The bladder may be located with an 18g hypodermic needle, giving more confidence in inserting the trocar into the bladder, as the track has already been secured by the guide wire.
  4. Improved insertion and removal. The safety guide wire improves insertion and removal, guaranteeing insertion of the trocar along the anesthetized track.
  5. Reduction in CAUTI - No Catheter Acquired Urinary Tract Infections reported.
  6. Reduces costs and hospital stay. The procedure rarely needs to be undertaken as an inpatient, under general anesthetic or in an operating room - reducing hospital stay, as well as reducing overall costs. Studies show length of stay can be reduced from 2.3 days to a procedure time of less than 29 minutes.
    (sources may be found via: http://www.s-cath.com/)

“In our market, we have found a great response from customers as they recognize the uniqueness of the S-Cath providing a more efficient method of delivering care to patients.” (T. Brady – CEO PSSU)

PSS Urology serves the needs of the Urology Surgical Device market with the highest quality products at an excellent value. Please contact us at 855-447-3222 or at info@pssurology.com for more information.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/pss-strengthens-relationship-with-mediplus-300802522.html

SOURCE PSS Urology

MORE ON THIS TOPIC